In order to reduce the high level of disabilities and stroke recurrence in cases of acute ischaemic stroke (AIS) it is vital that the diverse unmet needs are addressed, according to data and analytics company, GlobalData.
Stroke
A recent survey of key opinion leaders and high-prescribing physicians, performed by GlobalData, revealed that the most significant unmet need is the limited number of effective therapies available both during and after a stroke event.